AR046641A1 - Uso del (+)-(2s, 3s)-2-(3-clorofenil)-3,5,5-trimetil-2-morfolinol - Google Patents

Uso del (+)-(2s, 3s)-2-(3-clorofenil)-3,5,5-trimetil-2-morfolinol

Info

Publication number
AR046641A1
AR046641A1 ARP040104268A ARP040104268A AR046641A1 AR 046641 A1 AR046641 A1 AR 046641A1 AR P040104268 A ARP040104268 A AR P040104268A AR P040104268 A ARP040104268 A AR P040104268A AR 046641 A1 AR046641 A1 AR 046641A1
Authority
AR
Argentina
Prior art keywords
morpholinol
chlorophenyl
trimethyl
treatment
restless legs
Prior art date
Application number
ARP040104268A
Other languages
English (en)
Inventor
Jean Christophe Barland
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of AR046641A1 publication Critical patent/AR046641A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

El presente se refiere en particular a su uso en el tratamiento del Síndrome de piernas inquietas (SPI), o a su uso en el tratamiento de Trastorno de movimiento periódico de las piernas (TMPP). Reivindicación 1: Uso del (+)-(2S,3S)-2-(3-clorofenil)- 3,5,5-trimetil-2-morfolinol o una de sus sales o solvatos o sus composiciones farmacéuticas en la fabricación de un medicamento para tratar el Síndrome de piernas inquietas.
ARP040104268A 2003-11-21 2004-11-19 Uso del (+)-(2s, 3s)-2-(3-clorofenil)-3,5,5-trimetil-2-morfolinol AR046641A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0327195.4A GB0327195D0 (en) 2003-11-21 2003-11-21 Novel use

Publications (1)

Publication Number Publication Date
AR046641A1 true AR046641A1 (es) 2005-12-14

Family

ID=29764268

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040104268A AR046641A1 (es) 2003-11-21 2004-11-19 Uso del (+)-(2s, 3s)-2-(3-clorofenil)-3,5,5-trimetil-2-morfolinol

Country Status (7)

Country Link
US (1) US20070142378A1 (es)
EP (1) EP1684765A1 (es)
JP (1) JP2007511577A (es)
AR (1) AR046641A1 (es)
GB (1) GB0327195D0 (es)
TW (1) TW200529858A (es)
WO (1) WO2005053700A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0425445D0 (en) * 2004-11-18 2004-12-22 Smithkline Beecham Corp Novel compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1047428B1 (en) * 1998-01-21 2007-06-20 Glaxo Group Limited Use of morpholinol for the treatment of sexual dysfunction
US7098206B2 (en) * 1998-01-21 2006-08-29 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6342496B1 (en) * 1999-03-01 2002-01-29 Sepracor Inc. Bupropion metabolites and methods of use
US6337328B1 (en) * 1999-03-01 2002-01-08 Sepracor, Inc. Bupropion metabolites and methods of use
EP1336406A1 (en) * 2002-02-14 2003-08-20 Solvay Pharmaceuticals B.V. Partial dopamine-D2 receptor agonist plus serotonin and/or noradrenaline inhibitory activity

Also Published As

Publication number Publication date
US20070142378A1 (en) 2007-06-21
JP2007511577A (ja) 2007-05-10
TW200529858A (en) 2005-09-16
EP1684765A1 (en) 2006-08-02
GB0327195D0 (en) 2003-12-24
WO2005053700A1 (en) 2005-06-16

Similar Documents

Publication Publication Date Title
CY1113108T1 (el) Μεσυλικο προφαρμακου λεβοντοπα, συνθεσεις αυτου, και χρησεις αυτου
ECSP088763A (es) Nuevas combinaciones terapéuticas para el tratamiento de la depresión
CY1118179T1 (el) Φαρμακευτικη συνθεση
DE60336664D1 (de) Nichtnukleosidische reverse-transkriptase-hemmer
CY1113766T1 (el) Παραγωγα ινδολιδονης για την θεραπεια ή προληψη ινωτικων ασθενειων
CY1110965T1 (el) Επιπροσθετες ετεροπολυκυκλικες ενωσεις και η χρηση τους ως ανταγωνιστες μεταβολοτροπικου υποδοχεα γλουταμικου
EA200801138A1 (ru) Применение флибансерина для лечения расстройств полового влечения в предклимактерический период
RU2010129238A (ru) Применение производных изотиоцианата в качестве противомиеломных средств
CY1107419T1 (el) Προφαρμακα αντι-ιικων μεσων απο πιπεραζινη και υποκατεστημενη πιπεριδινη
CY1106589T1 (el) (s)-2-ν-προπυλαμινο-5-υδροξυτετραλινη ως d3-αγωνιστικο θεραπευτικο μεσο
AR051405A1 (es) Compuestos de 2-carboxamido(3-amino)tiofeno
AR109263A2 (es) Composición que comprende moxidectina
UY28098A1 (es) Derivados de anilinopirazol útiles en el tratamiento de la diabetes
GT200600409A (es) Uso de agomelatina para obtener medicamentos propuestos para el tratamiento de trastornos del sueño en el paciente deprimido.
CY1110130T1 (el) Παραγωγα μορφολινης για χρηση ως αγωνιστες ντοπαμινης στην θεραπευτικη αγωγη σεξουαλικης δυσλειτουργιας i.α.
AR077138A1 (es) Composiciones farmaceuticas utiles para tratar el vhc
AR077139A1 (es) Composiciones farmaceuticas utiles para tratar el vch
BRPI0417858A (pt) composto, composição farmacêutica, e, uso de uma composição farmacêutica
SE0302546D0 (sv) New compounds
UY27018A1 (es) Derivados de la pirimidina
UY29741A1 (es) Sales de 1,5- diaril pirazol-3-carboxamidas, procesos de preparación, composeciones farmacéuticas que las contienen, aplicaciones y métodos de uso.
EA200501821A1 (ru) Фармацевтическая комбинация, содержащая модафинил и другой лекарственный препарат
ECSP045397A (es) 6-ALQUILIDEN-PENEMS BICÍCLICOS COMO INHIBIDORES DE LAS b-LACTAMASAS
HRP20070291T3 (en) Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis
CR10255A (es) "nuevas composiciones terapéuticas para el tratamiento o la prevención de trastornos psicóticos"

Legal Events

Date Code Title Description
FB Suspension of granting procedure